LENZ Therapeutics's total assets for Q3 2024 were $224.01M, an increase of 10.54% from the previous quarter. LENZ total liabilities were $8.73M for the fiscal quarter, a -10.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.